Morgan Stanley acted as sole book running manager for the offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CGON:
- CG Oncology initiated with Buy on bladder cancer potential at BofA
- CG Oncology initiated with a Buy at BofA
- CG Oncology initiates EAP for Cretostimogene Grenadenorepvec in U.S.
- CG Oncology Initiates Expanded Access Program for Cretostimogene Grenadenorepvec
- CG Oncology Announces Nature Medicine Publication of Final Results from CORE-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab in BCG-Unresponsive NMIBC